HI
CANC icon

Harbour Investments’s Tema Oncology ETF CANC Stock Holding History

Harbour Investments’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-316
Closed -$7.61K – 3623
2025
Q1 		$7.61K Hold
316
– – ﹤0.01% 2646
2024
Q4 		$7.68K Hold
316
– – ﹤0.01% 2572
2024
Q3 		$8.98K Hold
316
– – ﹤0.01% 2399
2024
Q2 		$8.53K Hold
316
– – ﹤0.01% 2321
2024
Q1 		$8.88K Hold
316
– – ﹤0.01% 2271
2023
Q4 		$8.34K Buy
+316
New +$7.43K ﹤0.01% 2218

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Harbour Investments's CANC Position: Q2 2025 in Review

Harbour Investments sold out of Tema Oncology ETF (CANC) in Q2 2025, closing a stake of 316 shares — an estimated $7.61K sold.

Harbour Investments first reported a position in CANC in Q4 2023 and held it in 6 quarters. The position peaked at $8.98K in Q3 2024. 5 funds tracked by Wall St. Rank hold CANC as of Q2 2025.

  • Harbour Investments reported no remaining Tema Oncology ETF position as of Q2 2025 after selling out during the quarter.
  • Harbour Investments sold 316 Tema Oncology ETF shares in Q2 2025, an estimated $7.61K.
  • Harbour Investments first reported a position in Tema Oncology ETF in Q4 2023 and held it in 6 quarters.
  • Harbour Investments's Tema Oncology ETF position peaked at $8.98K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2025.

Based on Harbour Investments's 13F filing for Q2 2025, filed 28 Jul 2025.